Search
Search Results
##search.searchResults.foundPlural##
-
How I treat acute and persistent sickle cell pain
2032PDF: 1144HTML: 648 -
-
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6217PDF: 3416HTML: 9051Figure Malaria Ricci: 243 -
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection. Delivery in asymptomatic woman with SARS-CoV-2 infection
1958PDF: 1008HTML: 244 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
3058PDF: 1285HTML: 11855 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2840PDF: 1021HTML: 83 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2488PDF: 1625HTML: 673 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4187PDF: 1029HTML: 19208 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
928PDF: 673Suppl. Files: 139HTML: 129 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3209PDF: 1163HTML: 1679Untitled: 189Untitled: 184Untitled: 183 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1357PDF: 764HTML: 402 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS
2320PDF: 784HTML: 1286 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2678PDF: 1657HTML: 2440Table1: 206 -
-
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1633PDF: 516MP4: 438Html: 257 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1287PDF: 669HTML: 7752 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2233PDF: 941HTML: 1701 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3663PDF: 2574HTML: 1556 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
2736PDF: 1654HTML: 14662Untitled: 222Untitled: 187 -
POST-LOAD PLASMA GLUCOSE INCREASE (PG-GAP) AS A RISK FACTOR FOR DEVELOPING DYSGLYCEMIA IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (Β-TDT): RETROSPECTIVE ANALYSIS OVER 8 YEARS Post load plasma glucose increase and the risk of glucose dysregulation in thalassemia
550PDF: 267HTML: 122 -
-
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1925HTML: 1633PDF: 1134 -
-
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
157PDF: 139HTML: 41 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
994PDF: 587Html: 250Suppl. Files: 186 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
3022PDF: 638Suppl. Files: 299HTML: 267 -
-
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major
752PDF: 565Html: 136







